Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 19,654 shares at $28.80 ($571K) on 2024-04-17, disclosed to the SEC on 2024-04-19.
Open-market sale of $571k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.80 | 7,602 | $219K | 38.3% |
| 2 | $28.80 | 7,602 | $219K | 38.3% |
| 3 | $29.94 | 2,225 | $67K | 11.7% |
| 4 | $29.94 | 2,225 | $67K | 11.7% |
| Total | $29.06 avg | 19,654 | $571K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |